Published 3 days ago • loading... • Updated 2 days ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as a

+4 Reposted by 4 other sources

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as a

3 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources5

Leaning Left0Leaning Right0Center1Last Updated2 days agoBias Distribution

100% Center

100% Center

Untracked bias

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Carroll County Mirror-Democrat broke the news in Mount Carroll, United States 3 days ago on Friday, June 5, 2026.

Sources are mostly out of (0)